Abnormal expression of MLKL has been detected in many kinds of tumors, such as colon cancer, ovarian cancer, and gastric cancer34–36 and recent studies also have revealed that MLKL could serve as a potential prognostic biomarker for patients with cancer37–39. Here, MLKL is linked to ovarian carcinoma.